Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Adenoid Cystic × Epirubicin × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 4 Triple Negative Breast Neoplasms 3 Resectable HER2-positive Breast Cancer 1 Non-Muscle Invasive Bladder Neoplasms 1 Carcinoma, Adenoid Cystic 1

Interventions

pembrolizumab 2 Specimen Handling 2 Magnetic Resonance Spectroscopy 2 Pemetrexed 1 Nivolumab 1 Ipilimumab 1 Imatinib Mesylate 1 Glutamate Carboxypeptidase II 1 Epirubicin 1 Cyclophosphamide 1 Carboplatin 1 CTLA-4 Antigen 1 Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07320508 2026-01-21

EIC-SNACC

Eye & ENT Hospital of Fudan University

Phase 2 Recruiting

Carcinoma, Adenoid Cystic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡